Search results with tag "Renal cell carcinoma"
HIGHLIGHTS OF PRESCRIBING INFORMATION Proteinuria: …
www.accessdata.fda.gov1.2 Renal Cell Carcinoma LENVIMA is indicated in combination with everolimus for the treatment of patients with advanced renal cell carcinoma (RCC) following one prior anti-angiogenic therapy. 1.3 Hepatocellular Carcinoma LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
HIGHLIGHTS OF PRESCRIBING INFORMATION Gastric Cancer ...
packageinserts.bms.com1.3 Metastatic Non-Small Cell Lung Cancer 1.4 Malignant Pleural Mesothelioma 1.5 Advanced Renal Cell Carcinoma 1.6 Classical Hodgkin Lymphoma 1.7 Squamous Cell Carcinoma of the Head and Neck 1.8 Urothelial Carcinoma 1.9 Microsatellite Instability-High or Mismatch Repair Deficient Metastatic Colorectal Cancer 1.10 Hepatocellular Carcinoma
SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eusquamous cell carcinoma in adults whose tumours express PD-L1 with a ≥ 50% TPS and progressing on or after platinum-containing chemotherapy (see section 5.1). Renal cell carcinoma (RCC) KEYTRUDA, in combination with axitinib, is indicated for the first-line treatment of advanced renal cell carcinoma in adults (see section 5.1).
2017 2019 p
www.urol.or.jptreatment of renal cell carcinoma: results from the phase Ⅲ, randomized ATLAS trial. Ann Oncol. 2018; 29: 2371-8.（Ⅱ） 10）Motzer RJ, Haas NB, Donskov F, et al; PROTECT investigators. Randomized Phase Ⅲ Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.
HIGHLIGHTS OF PRESCRIBING INFORMATION
www.lenvima.com• For the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC). (1.1) Renal Cell Carcinoma (RCC) • In combination with pembrolizumab, for the first line treatment of adult patients with advanced renal cell carcinoma (RCC). (1.2)
NCCN Guidelines for Patients: Kidney Cancer
www.nccn.orgSep 08, 2021 · Renal cell carcinoma (RCC) is the most common type of kidney cancer. RCC can be broken down into subtypes by looking at the cancer cells under a microscope. This is called histology. Tumor histology and other factors are an important part of choosing a treatment plan. Clear cell RCC Clear cell RCC (ccRCC) is the most common subtype.
YERVOY U.S. Prescribing Information - BMS
packageinserts.bms.comRenal Cell Carcinoma (RCC) • Treatment of patients with intermediate or poor risk advanced renal cell carcinoma, as first-line treatment in combination with nivolumab. (1.3) Colorectal Cancer • Treatment of adult and pediatric patients 12 years and older with microsatellite
Bristol Myers Squibb - Global Biopharmaceutical Company
www.bms.comRenal Cell Carcinoma (RCC) subcutaneous nivolumab + rHuPH20+ OPDIVO@+ (nivolumab) (nivolumab) * YERVOY@+ ... Locally Advanced: 1st line SCCHN Esophageal: 15t line Esophageal: 15t line I st line Pediatric Adjuvant ... SCCHN = Squamous Cell Carcinoma of the Head & Neck HMA = Hypomethylating Agent
Epidemiology, Aetiology, and Pathogenesis of Renal Cell ...
eu-acme.orgEpidemiology, Aetiology, and Pathogenesis of Renal Cell Carcinoma Chris Protzel, Matthias Maruschke, Oliver W. Hakenberg* Department of Urology, Rostock University, Germany
prescribing information for AFINITOR/AFINITOR DISPERZ ...
www.novartis.us1.3 Renal Cell Carcinoma (RCC) AFINITOR is indicated for the treatment of adult patients with advanced RCC after failure of treatment with sunitinib or sorafenib. 1.4 Tuberous Sclerosis Complex (TSC)-Associated Renal Angiomyolipoma
Renal Cell Carcinoma in Adults 40 Years Old or Less: …
eu-acme.orgKidney Cancer Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival Xavier Taccoena, Antoine Valeria,*, Jean-Luc Descotesb, Vincent Morinc, Eric Stindelc, Laurent Doucetd, Vincent Joulina, Frederic Bocquerazb, Christian Coulangee, Jean-Jacques Rambeaudb, …